Galapagos Compound Unit Goes To Evotec | June 6, 2011 Issue - Vol. 89 Issue 23 | Chemical & Engineering News
Volume 89 Issue 23 | p. 25 | Concentrates
Issue Date: June 6, 2011

Galapagos Compound Unit Goes To Evotec

Department: Business
Keywords: compound management

Evotec has spent approximately $18 million to acquire Galapagos’ Compound Focus compound management unit. Located in South San Francisco, the business specializes in acquiring, formatting, storing, and shipping compound libraries for drug research labs (C&EN, April 11, page 24). It had sales of about $11 million last year. Evotec CEO Werner Lanthaler says the acquisition will strengthen his company’s existing compound management services and enhance its compound-screening platform. Galapagos says it will concentrate on drug discovery services through its Bio­Focus and Argenta businesses.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment